Tempest Therapeutics Announces Private Placement

Tempest Therapeutics has announced a private placement agreement, aiming to raise up to $6 million. This funding round is expected to provide the company with additional capital to support its ongoing operations and strategic initiatives. Specific details regarding the use of proceeds were not disclosed, but such placements typically fuel research and development, clinical trials, or business expansion. The announcement suggests a move to strengthen the company's financial position to advance its pipeline or market strategies.